Answers are grounded in this paper and cite their sources.
Purpose: The aim of this study is aimed to demonstrate the changes in the estrogen receptor (ER), progesterone receptor (PR), Ki-67, after neoadjuvant chemotherapy in the patients with locally advanced breast cancer. Materials and Methods: seventy patients who diagnosed with locally advanced breast cancer and treated with neoadjuvant chemotherapy. Ki-67, ER, PR, tested by immunohistochemistry (IHC) was evaluated before and after neoadjuvant chemotherapy. Results: There was a statistically significant reduction in Ki-67, but no statistically significant reduction in ER, PR, after neoadjuvant chemotherapy. Conclusion: The significant change in the Ki-67 proliferation index may suggest the reduced proliferative activity of malignant cells with neoadjuvant chemotherapy.
No takes yet. Share an insight, caveat, or question.
Sholkamy et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: